Clinical trial Recruiting at 1 site Interventional Ages 45 to 85

Comparing non-invasive electrical stimulation plus rehabilitation to improve balance and walking in Parkinson's disease

Official title: Neurotech PD Gait: Multisite Non-invasive Electrical Stimulation to Optimize Motor-cognitive Rehabilitation Response in Parkinson's Disease Subjects With Postural Instability and Gait Disorders

Run by IRCCS San Raffaele · NCT06868160 · Data updated 2026-11-12

This study will test whether adding different types of non-invasive electrical stimulation to gait and balance training helps people with Parkinson's disease who have postural instability and walking problems.

Quick facts

Study typeInterventional
Ages45 Years to 85 Years
SexAll
Enrollment71 (estimated)
SponsorIRCCS San Raffaele
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedOctober 8, 2025
Main results expectedOctober 2028
Study endsJanuary 2029
Registry record updatedDecember 3, 2025
Trial IDNCT06868160 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 45–85 with idiopathic Parkinson's disease of the PIGD phenotype, Hoehn & Yahr stage ≤4, stable dopaminergic medication, no dementia (MMSE ≥24), and able to undergo MRI and stimulation procedures.

Probably not a fit

Patients with major systemic, psychiatric, visual, musculoskeletal or other causes of walking inability, implanted electronic devices (e.g., pacemaker), uncontrolled medical conditions, or dementia are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with Parkinson's disease and postural instability/gait disorder (PD-PIGD) and age- and sex-matched healthy controls undergo baseline neurological, cognitive, gait/balance, neuroimaging (MRI), fNIRS, EEG, and blood assessments. PD-PIGD participants are randomized to two groups: REHAB+SHAM (dual-task gait/balance training with action observation and motor imagery plus sham stimulation) or REHAB+STIM (same training combined with active non-invasive electrical stimulation including tDCS and transcutaneous spinal DCS across two cycles). The protocol includes repeated training cycles with neurophysiological and imaging measures to track brain activity, connectivity, and structural changes over the observation period. Outcomes focus on gait and balance performance, biomarkers from imaging/EEG/fNIRS, and safety/tolerability of stimulation paired with rehabilitation.

Why it matters

Potential benefit: If successful, combining targeted electrical stimulation with gait and balance training could improve walking, reduce falls, and enhance mobility for patients with PD-PIGD.

How similar studies have gone: Previous small studies have shown promise for action observation/motor imagery and for noninvasive brain or spinal stimulation separately, but combining spinal and cranial stimulation with this rehab program is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 45 years \< age ≤ 85 years
* Idiopathic PD according to the Movement Disorders Society (MDS) diagnostic criteria
* Hoehn \& Yahr (H\&Y) score ≤ 4
* PIGD phenotype
* Stable dopaminergic medication for at least 4 weeks and without any changes during the observation period (28 weeks)
* No dementia according to Litvan\'s criteria and Mini-Mental Status Examination score (MMSE) ≥ 24
* No significant tremor/involuntary movements that could determine artifacts during the MRI acquisition
* Oral and written informed consent to study participation

Healthy controls' inclusion criteria:

* Sex-matched and age-matched (age range: mean age of PD years ± 15 years)
* Oral and written informed consent to study participation

Exclusion Criteria:

* Any major systemic, psychiatric, neurological, visual, and musculoskeletal disturbances or other causes of walking inability
* Medical conditions or substance abuse that could interfere with cognition
* Pacemaker or other implanted neurostimulation devices in the head/neck district
* (Other) Contraindications to undergoing MRI examination
* Brain damage at routine MRI, including extensive cerebrovascular disorders
* Denied oral and written informed consent to study participation
* Significant scalp traumatic or surgical wounds or scalp alterations that could determine a risk of infection in the site of non-invasive stimulation or the spread of excessive current from the device (only for patients receiving the neurostimulation).

Where it's running

  • San Raffaele Neurotech Hub
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.